Safety and efficacy of single‐agent docetaxel ( T axotere) administered weekly in non‐small cell lung carcinoma patients in K orea: An observational study

Author:

Lim Sun Min12,Park Byeong Bae3,Park Keun‐Chil4,Kim Hoon‐Kyo5,Lee Jong Seok6,Bae Sung Hwa7,Lee Seung‐Sei8,Kang Jin‐Hyoung9,Park Se‐Hoon4,Lee Gyeong‐Won10,Lee Hyo‐Rac11,Seo Jae Hong12,Kim Yong Tae11,Yang Sung Hyun13,Kim Joo‐Hang1

Affiliation:

1. Division of Medical Oncology Department of Internal Medicine Yonsei Cancer Center Seoul Korea

2. Division of Medical Oncology Department of Internal Medicine CHA University Bundang Medical Center Seongnam Korea

3. Hanyang University College of Medicine Division of Hematology‐Oncology Department of Internal Medicine Seoul Korea

4. Samsung Medical Center Department of Hematology‐Oncology Seoul Korea

5. St. Vincent Hospital Department of Oncology Gyeonggi‐do Korea

6. Seoul National University Bundang Hospital Gyeonggi‐do Korea

7. Daegu Catholic University Hospital Daegu Korea

8. Kangbuk Samsung Medical Center Seoul Korea

9. The Catholic University of Korea Seoul St. Mary's Hospital Seoul Korea

10. Gyeongsang National University Hospital Gyeongsang National University School of Medicine Gyeongnam Korea

11. NHIC Ilsan Hospital Gyeonggi‐do Korea

12. Korea University Guro Hospital Seoul Korea

13. Korea Cancer Center Hospital Seoul Korea

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Reference28 articles.

1. International Agency for Research on Cancer.Lung cancer incidence and mortality worldwide in 2008. GLOBOCAN 2008 Fact Sheet2008. [Cited 24 Mar 2011.] Available from URL:http://globocan.iarc.fr/factsheets/cancers/lung.asp.

2. Amercian Cancer Society.Global cancer facts and figures. ACS;2015. [Cited 5 Aug 2015.] Available from URL:http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2015/.

3. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

4. Current Treatments for Advanced Stage Non-Small Cell Lung Cancer

5. Multidisciplinary Management of Lung Cancer

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3